Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.
The FDA has accepted for review the NDA for bumetanide nasal spray for edema associated with CHF, as well as hepatic and renal disease.
The U.S. Food and Drug Administration is recalling 89,312 bottles of NasoGel nasal spray because the product might cause ...
The recalled products were sold across 32 states — including Massachusetts, Connecticut, Rhode Island and Vermont.
STATEN ISLAND, N.Y. — The U.S. Food and Drug Administration (FDA) has announced a recall of 89,312 bottles of a popular nasal ...
Retired electrician Joe Walsh in December became the first Alzheimer’s patient to try a nasal spray used to treat other ...
There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...
A Prescription Drug User Fee Act target date of September 14, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application ...
Just a few puffs into each nostril, and you're protected against infection from nasty cold viruses - that is, according to claims made for many nasal sprays. Can they really do this?Well, not directly ...
The drug is designed to reduce inflammation in the brain and has been used on MS, cancer and migraine headaches.